technical situation
Coenzyme Q10
Introduction to the process technology of this project
Japan is the world's earliest and most important producer of Coenzyme Q10, and the two Japanese companies with the highest Coenzyme Q10 production, "Nissin Milling" and "Kyowa Fermentation Co., Ltd.", have significant advantages in industrial production technology and promoting digestion and absorption.
Through the absorption and optimization of the existing process in Japan, the design of the complete set of process technology of this project was completed by using stable and large-scale production of high-quality coenzyme Q10 strains (Trichobacterium erythrophila, Trichobacterium denitrification, Microcyclic methane, etc.), which maximized the yield of coenzyme Q10.
The process technology design capacity of this project is 500 tons, the potency is 3300 (mg l), and the dry slag content is 36%, sugar consumption 95kg kg. Its fermentation technology is 5%-10% ahead of domestic first-line companies, and its separation and purification technology is equivalent to that of domestic first-line companies.
efficacy & technology
Coenzyme Q10
Efficacy and technology
Coenzyme Q10 is an important hydrogen transmitter in the cellular respiratory chain and an important component of intracellular ATP synthesis.
Coenzyme Q10 is widely found in the heart, liver, kidney and other parts of the human body, among which the highest concentration in the heart, is a cardiomyocyte energy metabolism agonist and a high-efficiency antioxidant, can effectively improve the symptoms of heart failure, improve cardiac function and reduce the lethality rate, has the effect of assisting in lowering blood pressure, preventing arteriosclerosis, etc., and has a good application prospect in the improvement of cardiovascular problems.
In recent years, with the deepening of research, coenzyme Q10 has been confirmed to have many health effects such as antioxidant properties, free radical scavenging, enhancing human immunity, anti-tumor, anti-aging, regulating blood lipids, enhancing brain power, relieving fatigue and improving exercise ability. In addition to medicinal use, coenzyme Q10 has been widely used in health foods, dietary nutritional supplements and high-end cosmetics.
Preparation methods of coenzyme Q10 on the market:
Ben
item
Purpose
work
Art
technology
technology
Promising production methods.
The technology of this project consists of microbial cell fermentation process and cell disruption and extraction method. The raw materials used in the preparation of coenzyme Q10 by this method are abundant, the separation process is simple, and the product obtained is a natural substance, with good biological activity, easy to be absorbed by the human body, and has a good antioxidant function.
Microbial cell fermentation process: the technology is 5%-10% ahead of domestic first-line companies.
Cell disruption extraction.
unlimited potential
Coenzyme Q10
Products with predictable technological potential
Coenzyme Q10 is the only one of the 18 vitamins and vitamins with industrial level that has: microbial fermentation productionThe product value is high;The market is big enough;Products with predictable technical potential.
1. The market space has unlimited potential.
The annual market size of 20-3 billion yuan brought by direct sales of products;The market size of related industries exceeds 10 billion.
2. Technology and team advantages.
At present, the two leading companies in fermentation and separation and purification technology are Jindawei and Xinhecheng, and the fermentation advantage of this technology is 5%-10% ahead of Jindawei, and the separation and purification advantages are equivalent to Xinhecheng.
The team is led by the best technical experts and production site experts in China.
The technical potential is huge, and the pilot scale has achieved great technical improvement.
3. The window period of about 3 years in the next 3 years.
In the next three years, it will be in the "release capacity cycle (Jindawei, Shenzhou Biotech, Xinhecheng), commissioning cycle (Yuxing), and potential entrant production cycle".
relevant data
Coenzyme Q10
Comparison of benchmark company data
At present, the transaction volume of coenzyme Q10 is 1500 yuan kg, and the market size has exceeded 10 billion. Relevant enterprises have begun to investigate or develop the product on a small scale, such as: Zhejiang Hisun, Xinjiang, Ningxia and some enterprises in Jiangsu.
The world's major coenzyme Q10 manufacturers and capacity cost estimates
Comparison of key technical indicators of coenzyme Q10
Note: Manufacturer's information will not be disclosed confidential.
future strategy
Coenzyme Q10
and NMN's future competitive strategy
NMN (nicotinamide mononucleotide), as a precursor substance of the important coenzyme NAD+ in the human body, can form a synergistic effect with coenzyme Q10 and extend downstream to make health care products, cosmetics and other products.